Temozolomide Suppliers & Bulk Manufacturers

Available Forms: Capsule and Powder for reconstitution

Available Strengths: Capsule( 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, 250 mg); Powder( 100 mg/vial)

Reference Brands: Temodar(US), Temodal (EU)

Category: Oncology Cancer Care

Temozolomide is available in Capsule and Powder for reconstitution and strengths such as Capsule( 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, 250 mg); Powder( 100 mg/vial). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Temozolomide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Temozolomide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Temozolomide (Temodar/Temodal) is a potent oral alkylating chemotherapy agent used in the treatment of glioblastoma multiforme and anaplastic astrocytoma. Approved by the FDA (as Temodar) and EMA (as Temodal), it is available in capsule strengths of 5 mg to 250 mg and as a 100 mg injectable vial for IV use. Widely used in neuro-oncology protocols, Temozolomide offers excellent bioavailability and treatment compliance. Multiple generic versions are available from trusted global manufacturers. Ideal for pharmaceutical B2B partners in the US and EU seeking reliable oncology portfolio expansion. Contact us for bulk API supply, licensing, or third-party manufacturing.